New orphan drug (clobazam-Onfi) approved for Lennox-Gastaut seizures

young girl climbing wall  Some types of seizures are difficult to control. This is certainly true of Lennox-Gastaut syndrome. the FDA has approved cobazam (Onfi) as add-on therapy to treat seizures in children 2 years or older and adults.

Approval Date: 
Mon, 10/24/2011

Two diseases treated with one pill (Juvisync-sitagliptin, simvastatin) ?

2 people in kayak The FDA has approved a new dynamic duo which treats both diabetes and abnormal cholesterol. Juvisync combines a diabetes medicine called sitagliptin (Januvia) with a bad cholesterol lowering medicine called simvastatin (Zocor).

Dr. Rybacki Overcoming Osteoporosis on WILL Focus 580

woman eating October 20th is World Osteoporosis day and we all need to be more proactive and aware in preventing osteoporosis! The Editor will be giving an interview (""Overcoming Osteoporosis""
Air date: Thursday, October 20, 2011, 11am

The Essential Guide to Medical News (Overcoming Osteoporosis)

Osteoporosis risk, prevention and new treatment

Have you overdrawn your bone bank and ended up with osteoporosis? Find out about Prolia (denosumab), a strong new medicine for weak bones. See if you have any of the 5 crucial risk factors that can lead to brittle bones, know how much calcium you really need each day and meet our guest editor, Dr. Mary Bouxsein from Harvard. Six detail packed pages in this easy to understand newsletter.


Comb-Bound Booklet.


B Vitamins might delay Alzheimer's

woman on steep stairs News from the British Science festival and from International Psychiatry and several British newspapers may show tremendous hope for people at risk for and alreading showing mild impairment con

This website is not intended as medical advice, and you should consult your doctor before changing or adding any medicines or vitamins to those you may now be taking and about applying any strategies BEFORE you adopt any approach in this report. While diligent care has been taken to ensure the accuracy of the information provided during the preparation of this edition, no claim is made that all known actions, uses or side effects, strategies for cost containment, targets or cholesterol pathways are included in this report. The accuracy and currentness of information are ever subject to change relative to new guidelines, new information derived from drug research, development and general usage.